MedPage Today on MSN
Color blindness and bladder cancer: A bad combination for survival?
People with color vision deficiency -- commonly known as color blindness -- may have a higher risk of mortality from bladder ...
People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...
A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.
Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.
ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.
An existing oral drug already used to treat lung cancer could help improve survival rates for bladder cancer patients, a new clinical trial by UK scientists has found. There are approximately 10,300 ...
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
A new treatment for advanced bladder cancer which doubles survival time has been approved for NHS use. The treatment for advanced bladder cancer had not significantly changed since the 1980s. Now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback